Abstract
In this report we describe our experience with two patients in order to evaluate the clinical potential of a reduced intensity stem cell transplantation in a more difficult clinical setting, i.e. second transplant with a one- or two-antigen mismatched related donor for relapsed and refractory leukemia. Three benefits were hoped for: 1) reduced regimen-related toxicity, 2) potent engraftment facilitation, and 3) an intense anti-leukemia effect.
Original language | English (US) |
---|---|
Pages (from-to) | 780-781 |
Number of pages | 2 |
Journal | Haematologica |
Volume | 86 |
Issue number | 7 |
State | Published - Aug 7 2001 |
All Science Journal Classification (ASJC) codes
- Hematology